Abstract:Highlights • FGF21 expression in hepatocytes and macrophages is upregulated during sepsis. • FGF21 inhibits proinflammatory macrophage activation by resuming autophagy flux to ameliorate septic liver injury. • FGF21 accelerates autolysosome degradation via mTOR signaling, while it has no effect on autophagosome formation induced by LPS via ERK and JNK signaling pathways. • FGF21 promotes p62-dependent autophagic degradation of HIF-1α in macrophages by enhancing the interaction between p62 and HIF-1α. Introduction Sepsis, a systemic immune syndrome caused by severe trauma or infection, poses a substantial threat to the health of patients worldwide. The progression of sepsis is heavily influenced by septic liver injury, which is triggered by infection and cytokine storms, and has a significant impact on the tolerance and prognosis of septic patients. The objective of our study is to elucidate the biological role and molecular mechanism of fibroblast growth factor 21 (FGF21) in the process of sepsis. Objectives This study was undertaken in an attempt to elucidate the function and molecular mechanism of FGF21 in therapy of sepsis. Methods Serum concentrations of FGF21 were measured in sepsis patients and septic mice. Liver injury was compared between mice FGF21 knockout (KO) mice and wildtype (WT) mice. To assess the therapeutic potential, recombinant human FGF21 was administered to septic mice. Furthermore, the molecular mechanism of FGF21 was investigated in mice with myeloid-cell specific HIF-1α overexpression mice (LyzM-Cre DIO-HIF-1α ) and myeloid-cell specific Atg7 knockout mice ( Atg7 △mye ). Results Serum level of FGF21 was significantly increased in sepsis patients and septic mice. Through the use of recombinant human FGF21 (rhFGF21) and FGF21 KO mice, we found that FGF21 mitigated septic liver injury by inhibiting the initiation and propagation of inflammation. Treatment with rhFGF21 effectively suppressed the activation of proinflammatory macrophages by promoting macroautophagy/autophagy degradation of hypoxia-inducible factor-1α (HIF-1α). Importantly, the therapeutic effect of rhFGF21 against septic liver injury was nullified in LyzM-Cre DIO-HIF-1α mice and Atg7 △mye mice. Conclusions Our findings demonstrate that FGF21 considerably suppresses inflammation upon septic liver injury through the autophagy/ HIF-1α axis. Graphical abstract Schematic showing that FGF21 alleviates septic liver injury by inhibiting proinflammatory activation of macrophages by promoting autophagic degradation of HIF-1α. Download : Download high-res image (242KB) Download : Download full-size image

Cardioprotective Role of Myocardial Ischemia-Induced Hepatic FGF21

Endocrine Protection of Ischemic Myocardium by Fgf21 from the Liver and Adipose Tissue

Abstract P278: Fibroblast Growth Factor 21 Mediated Protection of Ischemic Myocardium

FGF21 protects against ischaemia reperfusion injury in normal and fatty livers

Fibroblast Growth Factor 21 Protects Against Pathological Cardiac Remodeling by Modulating Galectin-3 Expression

Cardioprotective proteins upregulated in the liver in response to experimental myocardial ischemia.

The Protective Role of Bfgf in Myocardial Infarction and Hypoxia Cardiomyocytes by Reducing Oxidative Stress Via Nrf2

Fibroblast growth factor 21 inhibited inflammation and fibrosis after myocardial infarction via EGR1

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway

FGF21-FGFR1 Controls Mitochondrial Homeostasis in Cardiomyocytes by Modulating the Degradation of OPA1

FGF21 Promotes Myocardial Angiogenesis and Mediates the Cardioprotective Effects of Exercise in Myocardial Infarction Mice.

Fibroblast Growth Factor 21 Suppressed Neutrophil Extracellular Traps Induced by Myocardial Ischemia/Reperfusion Injury via Adenosine Monophosphate-Activated Protein Kinase

Research progress of fibroblast growth factor 21 on myocardial protection

Fibroblast Growth Factor 21 Ameliorates NaV1.5 and Kir2.1 Channel Dysregulation in Human AC16 Cardiomyocytes

Fibroblast growth factor 21 attenuates pulmonary ischemia/reperfusion injury via inhibiting endoplasmic reticulum stress-induced ferroptosis though FGFR1/PPARδ signaling pathway

Overexpression of FGF19 Alleviates Hypoxia/reoxygenation-Induced Injury of Cardiomyocytes by Regulating GSK-3β/Nrf2/ARE Signaling.

FGF21 modulates immunometabolic homeostasis via the ALOX15/15-HETE axis in early liver graft injury

Liver-heart Crosstalk Controls IL-22 Activity in Cardiac Protection after Myocardial Infarction

FGF21 protects against doxorubicin-induced cardiotoxicity by inhibiting connexin 43 ubiquitination

Fibroblast growth factor 21 inhibited ischemic arrhythmias via targeting miR-143/EGR1 axis

FGF21 ameliorates septic liver injury by restraining proinflammatory macrophages activation through the autophagy/HIF-1α axis